Henry Schein (Henry Schein) Risk Assessment

View and export this data going back to 1995. Start your Free Trial

What is Henry Schein Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Henry Schein is: Low Risk: Strong fundamentals, worth long-term holding.

Competitive Comparison of Henry Schein's Risk Assessment

For the Medical Distribution subindustry, Henry Schein's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Henry Schein's Risk Assessment Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Henry Schein's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Henry Schein's Risk Assessment falls into.

Henry Schein (NAS:HSIC) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Henry Schein Risk Assessment Related Terms

Thank you for viewing the detailed overview of Henry Schein's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Henry Schein (Henry Schein) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Henry Schein Inc (NAS:HSIC) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

HS2:Germany

Address

135 Duryea Road, Melville, NY, USA, 11747

Website

https://www.henryschein.com

Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services primarily to office-based dental and medical practitioners, as well as alternate sites of care. The company operates in two reportable segments; health care distribution and technology & value-added services. The healthcare distribution segment is engaged in combining global dental and medical businesses and distributes consumable products, small equipment, laboratory products, and Vitamins. The technology and value-added services reportable segment provides software, technology & other value-added services to health care practitioners. The majority of revenue is derived from the health care distribution segment.

Executives

Stanley M Bergman	director, officer: President and CEO	C/O HENRY SCHEIN INC, 135 DURYEA ROAD, MELVILLE NY 11747
Bradford C Connett	officer: CEO, NA Distribution Group	C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747
Brous David B Jr	officer: CEO, Strategic Business Group	C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747
Walter Siegel	officer: Senior VP & General Counsel	C/O HENRY SCHEIN, INC, 135 DURYEA RD, MELVILLE NY 11747
James P Breslawski	director, officer: Executive Vice President	C/O HENRY SCHEIN INC, 135 DURYEA RD, MELVILLE NY 11747
Michael S Ettinger	officer: SVP, General Counsel, Sec.	C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747
Mark E Mlotek	director, officer: SVP, Corp Bus Dev Group	C/O HENRY SCHEIN INC, 135 DURYEA RD, MELVILLE NY 11747
Lorelei Mcglynn	officer: SVP, Global HR & Fin. Oper.	C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747
Gerald A Benjamin	director, officer: Executive V.P and CAO	C/O HENRY SCHEIN, INC, 135 DURYEA RD, MELVILLE NY 11747
Ronald N. South	officer: SVP & Chief Financial Officer	C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747
Philip A Laskawy	director	9 CREAMER HILL ROAD, GREENWICH CT 06831
Kurt P Kuehn	director	C/O HENRY SCHEIN, INC, 135 DURYEA ROAD, MELVILLE NY 11747
Scott Philip Serota	director	C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747
Reed Vaughn Tuckson	director	C/O UNITEDHEALTH GROUP INCORPORATED, 9900 BREN ROAD EAST, MINNETONKA MN 55123
Steven Paladino	director, officer: Executive V.P. and CFO	C/O HENRY SCHEIN INC, 135 DURYEA RD, MELVILLE NY 11747